Mode
Text Size
Log in / Sign up
Phase 2 N=12 Randomized Triple-blind Treatment

Use of Resveratrol to Decrease Acute Secondary Brain Injury Following Sports-Related Concussions in Boxers

Sports Concussion

Enrolled (actual)
12
Serious AEs
0.0%
Results posted
Feb 2021
Primary outcome: Primary: Liver Function Testing (Aspartate Transaminase [AST]/Alanine Transaminase [ALT] Ratios) to Screen for Adverse Events. — 1.57; 1.24 AST/ALT ratio

Study Design & Population

Study type
Interventional
Phase
Phase 2
Interventions
Resveratrol (Drug); Placebo (Drug)
Age
Adult · 18+ yrs
Sex
All
Sponsor
University of Texas Southwestern Medical Center
Primary completion
Nov 2011

Outcome Measures

OutcomeResultp-value
PRIMARY
Liver Function Testing (Aspartate Transaminase [AST]/Alanine Transaminase [ALT] Ratios) to Screen for Adverse Events.
PRIMARY
Liver Function Testing (Aspartate Transaminase [AST]/Alanine Transaminase [ALT] Ratios) to Screen for Adverse Events.
SECONDARY
Functional Connectivity in Concussed Boxers
SECONDARY
Reaction Time Composite as Assessed by Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) Cognitive Test Performance
SECONDARY
Reaction Time Composite as Assessed by Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) Cognitive Test Performance
SECONDARY
Reaction Time Composite as Assessed by Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT) Cognitive Test Performance

Summary

Sports-related concussions are a serious problem in football, boxing, and other full contact sports. After experiencing consecutive concussions, there is an increase in neurological deficits that can lead to long-term cognitive problems (Dementia pugilistica). To combat this increase in brain damage, novel strategies need to be developed to protect athletes that are participating in these full contact sports. The purpose of this study is to elucidate whether resveratrol decreases brain injury and improves brain function after experiencing a concussion in boxers.

Eligibility Criteria

Inclusion Criteria

  • Boxers between the ages 18-35 years old
  • Both men and women
  • Boxers with an estimated concussion (Mild and Moderate) as estimated by the on-site physician or athletic trainer
  • Subject has provided full written informed consent prior to the performance of any protocol-specified procedure

Exclusion Criteria

  • Immediate hospitalization for sports-related concussion (Severe Concussion)
  • Known inclusion in an interventional clinical trial
  • Patients with metal implants that would interfere with the MRI scan
  • Known anemia
  • Known Pregnancy
  • Known history of alcohol/drug abuse
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01321151). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search